Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)

C. Faivre-Finn, F. Blackhall, N. Thatcher, P. Taylor, L. Ashcroft, C. Rowbottom, P. Lorigan

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)7583-7583
Number of pages1
JournalJournal of Clinical Oncology
Issue number15_suppl
Publication statusPublished - 24 Feb 2017

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this